Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort

Blood Adv (2023) 7 (21): 6630–6638.

https://doi.org/10.1182/bloodadvances.2023010622

Published: 2023

Includes: Supplemental data

Journal Articles

Older patients with chronic myeloid leukemia face suboptimal molecular testing and tyrosine kinase inhibitor adherence

Rory M. Shallis, Rong Wang, Amer M. Zeidan, Scott F. Huntington, Natalia Neparidze, Jessica M. Stempel, Lourdes M. Mendez, Mengyang Di, Xiaomei Ma, Nikolai A. Podoltsev

Blood Adv (2023) 7 (13): 3213–3224.

https://doi.org/10.1182/bloodadvances.2022009074

Published: 2023

Journal Articles

Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma

Kunal C. Potnis, Mengyang Di, Iris Isufi, Lohith Gowda, Stuart E. Seropian, Francine M. Foss, Howard P. Forman, Scott F. Huntington

Blood Adv (2023) 7 (5): 801–810.

https://doi.org/10.1182/bloodadvances.2022008097

Published: 2023

Includes: Supplemental data

Journal Articles

Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis

Mengyang Di, Can Cui, Shalin K. Kothari, Amer M. Zeidan, Nikolai A. Podoltsev, Natalia Neparidze, Rory M. Shallis, Rong Wang, Xiaomei Ma, Scott F. Huntington

Blood Adv (2022) 6 (11): 3339–3342.

https://doi.org/10.1182/bloodadvances.2021006934

Published: 2022

Includes: Supplemental data